EUVIMEDEUVIMED entdecken
Crossref

Design, development and evaluation of curcumin (Curcuma longa) encapsulated phospholipid nanocarrier to enhance solubility and improve efficacy in MCF-7 cell line by Quality by Design

Vaibhav Bhadange, Supriya Jogdand, Ankita Kawtikwar, Pravin Kawtikwar

Annales Pharmaceutiques Françaises · 2025

DOI: 10.1016/j.pharma.2025.07.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annales Pharmaceutiques Françaises, 2025. Verfasst von Vaibhav Bhadange und 3 weiteren Autor:innen. Beteiligte Einrichtung: Sudhakarrao Naik Institute of Pharmacy, Nagpur Road, SH-183, District Yavatmal, Pusad, Maharashtra 445215, India; Amity Institute of Pharmacy, Amity …. Hauptthemen laut MEDLINE: Curcumin, Phospholipids, Antineoplastic Agents, Phytogenic. Die Arbeit nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lipid-based excipients are increasingly used to enhance the stability of innovative drug delivery systems. Phospoholipid nanocarriers, a botanical formulation, are used to build lipophilic molecular complexes, improving stability, absorption, and bioavailability. Turmeric (Curcuma longa) contains curcumin, which has poor bioavailability due to its solubility and wettability. Hence, the study was designed to enhance the solubility of curcumin by phospholipid complexation. The curcumin-encapsulated phospholipid nanocarriers (Ccm-PNs) were developed by solvent evaporation method, and the formula was optimized using a Box-Behnekn design based on QbD. Physicochemical properties and functional characterization were done by accessing particle size, entrapment efficiency, in vitro drug release. The adenocarcinoma breast cell line (MCF-7) was used for cytotoxicity investigation of Ccm-PNs. It showed lower particle size and stable zeta potential values, and their compatibility with excipients was confirmed through DSC and FTIR studies. They also demonstrated higher entrapment and in vitro drug release over 48hours. The cytotoxicity study showed improved efficacy than pure curcumin solution. In conclusion, overall results show that phospholipid nanocarriers have the ability to enhance therapeutic efficacy and bioavailability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CurcuminPhospholipidsAntineoplastic Agents, PhytogenicHumansSolubilityMCF-7 CellsDrug CarriersNanoparticlesParticle SizeDrug LiberationDrug DesignCell SurvivalDrug CompoundingCurcuma

Stichwörter der Autor:innen

BioavailabilityBiodisponibilitéCurcuminCurcumineEfficacité amélioréeImproved efficacyLa qualité dès la conceptionNanotransporteurs de phospholipidesPhospholipid nanocarriersQuality by Design

Substanzen

CurcuminPhospholipidsDrug CarriersAntineoplastic Agents, Phytogenic

Autor:innen und Institutionen

  • Sudhakarrao Naik Institute of Pharmacy, Nagpur Road, SH-183, District Yavatmal, Pusad, Maharashtra 445215, India; Amity Institute of Pharmacy, Amity University Maharashtra, Panvel, Mumbai 410206, India. Electronic addre…
  • Vidyabharati College of Pharmacy, Amravati, Maharashtra 444604, India.
  • Sudhakarrao Naik Institute of Pharmacy, Nagpur Road, SH-183, District Yavatmal, Pusad, Maharashtra 445215, India.

Zitieren

APA

Bhadange, V., Jogdand, S., Kawtikwar, A., & Kawtikwar, P. (2025). Design, development and evaluation of curcumin (Curcuma longa) encapsulated phospholipid nanocarrier to enhance solubility and improve efficacy in MCF-7 cell line by Quality by Design. Annales Pharmaceutiques Françaises. https://doi.org/10.1016/j.pharma.2025.07.004

Vancouver

Bhadange V, Jogdand S, Kawtikwar A, Kawtikwar P. Design, development and evaluation of curcumin (Curcuma longa) encapsulated phospholipid nanocarrier to enhance solubility and improve efficacy in MCF-7 cell line by Quality by Design. Annales Pharmaceutiques Françaises. 2025. doi:10.1016/j.pharma.2025.07.004

BibTeX
@article{Bhadange2025,
  author = {Bhadange, Vaibhav and Jogdand, Supriya and Kawtikwar, Ankita and Kawtikwar, Pravin},
  title = {Design, development and evaluation of curcumin (Curcuma longa) encapsulated phospholipid nanocarrier to enhance solubility and improve efficacy in MCF-7 cell line by Quality by Design},
  journal = {Annales Pharmaceutiques Françaises},
  year = {2025},
  doi = {10.1016/j.pharma.2025.07.004}
}
Kostenlos starten →